Global Injectable Drug Delivery Market – Industry Trends and Forecast to 2024

1. Injectable Drug Delivery Market – Industry Trends and Forecast to 2024 Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), Geography (North America, Europe, Asia- Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024 Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Request delivery-market for TOC@ http://databridgemarketresearch.com/toc/?dbmr=global-injectable-drug- Injectable Drug Delivery Market – Market Segmentation: Injectable drug delivery device market is segmented into conventional injection devices and self- injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. In 2017, the hospital &clinics segment is expected to dominate the market and is expected to continue this trend till 2024. Browse Full Report with Details TOC @ http://databridgemarketresearch.com/reports/global- injectable-drug-delivery-market/ Based on geography, the market is segmented into five geographical regions: North America Europe Asia-Pacific

2. South America Middle East and Africa The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others. Table Of Content : 1. INTRODUCTION 1.1. OVERVIEW OF GLOBAL INJECTABLEDRUG DELIVERY MARKET 1.2. CURRENCY AND PRICING 1.3. LIMITATION 1.4. MARKETS COVERED 2. MARKET SEGMENTATION 2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS 3. MARKET OVERVIEW 3.1. DRIVERS 3.2. RESTRAINTS 3.4. CHALLENGES 4. EXECUTIVE SUMMARY 5. PREMIUM INSIGHTS 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET, REGULATORY 6.1. OVERVIEW 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE 7.1. OVERVIEW

3. 7.2. INJECTABLE DRUG DELIVERY DEVICES 7.3. INJECTABLE DRUG DELIVERY FORMULATION 7.3.2. NOVEL DRUG DELIVERY FORMULATIONS 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION 8.1. OVERVIEW 8.2. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION 8.3. HORMONAL DISORDERS 8.4. ONCOLOGY 8.5. AUTOIMMUNE DISEASES 8.6. ORPHAN DISEASE 8.7. OTHER APPLICATIONS 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 9.1. OVERVIEW 9.2. CURATIVE CARE 9.3. IMMUNIZATIONS 9.4. OTHER USAGE PATTERN 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION 10.1. OVERVIEW 10.2. SKIN 10.3. CIRCULATORY/ MUSKOSKELETAL 10.4. ORGANS 10.5. CENTRAL NERVOUS SYSTEM 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END USER 11.1. OVERVIEW 11.2. HOSPITALS AND CLINICS 11.3. HOME HEALTHCARE SETTINGS 11.4. RESEARCH LABORATORIES 11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES 11.6. OTHER END USERS 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 12.1. OVERVIEW

4. 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY 13.3. EUROPE INJECTABLE DRUG DELIVERY MARKET 13.4. APAC INJECTABLE DRUG DELIVERY MARKET 13.5. SOUTH AMERICA INJECTABLE DRUG DELIVERY MARKET 13.6. MEA INJECTABLE DRUG DELIVERY MARKET 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE 14.1. COMPANY SHARE ANALYSIS: GLOBAL 15. COMPANY PROFILES 15.1. BECTON, DICKINSON AND COMPANY 15.2. PFIZER 15.3. BAXTER INTERNATIONAL 15.4. GERRESHEIMER AG 15.6. ALKERMES INC. 15.7. ANTARES PHARMA 15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY) 15.9. ELCAM MEDICAL 15.10. ELI LILLY AND COMPANY 15.11. HASELMEIER 15.12. MYLAN N.V. 15.13. NOVO NORDISK 15.14. OWEN MUMFORD LTD 15.15. SANDOZ INTERNATIONAL GMBH 15.16. SANOFI

5. 15.17. TERUMO CORPORATION 15.18. TEVA PHARMACEUTICAL Request For Sample: injectable-drug-delivery-market http://databridgemarketresearch.com/request-a-sample/?dbmr=global- Some of the major players operating in this market are Becton Dickinson and company is going to dominate the injectable drug delivery market following with Pfizer and Baxter International, Inc., along with others such as Gerresheimer AG, Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Bespak, Antares Pharma,Elcam Medical, Haselmeier, Mylan N.V., Novo Nordisk, Owen Mumford Ltd, Sanofi, West Pharmaceutical Services, Inc, Ypsomed Holding AG. Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before- buying/?dbmr=global-injectable-drug-delivery-market Related Report Global Hemostats Market- Trends and Forecast to 2024 Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024 http://databridgemarketresearch.com/reports/global-hemostats-market/ About Data Bridge Market Research: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Contact: Vishal Dixit Data Bridge Market Research Tel: +1-888-387-2818 Email: Sales@databridgemarketresearch.com Investor: investors@databridgemarketresearch.com Visit Blog http://databridgemarketresearch.com/blog/